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However, the role and properties of oxygen delivery and consump-
tion have remained unclear. For instance, steady-state increases in 
oxygen delivery have been consistently observed to exceed the state-
state increases in oxygen consumption by a ratio between 2 and 3 
(Uludag et al., 2004). It is this disproportionate ratio that is exploited 
to image brain function in humans and animals using methods 
like BOLD fMRI. Fueling our lack of understanding is the fact that 
neural activity is a highly dynamic process and dynamic measure-
ments of oxygen consumption (and delivery) have been largely 
unavailable. As a result, the use of blood oxygenation methods to 
interpret and quantify brain function remains uncertain. Because 
these processes are not simple and many important variables are 
not routinely measured, models have been employed to explore, 
interpret and quantify the dynamics of this process (Zheng et al., 
2002; Valabregue et al., 2003; Huppert et al., 2007; Boas et al., 2008). 
However, the dynamic properties of tissue oxygen consumption with 
changes in brain function have been difficult to measure, leaving 
this portion of the model to educated assumptions.
A thorough understanding of cerebral oxygen delivery and con-
sumption is important not only to understand this fundamental 
metabolic process but also for the quantification of the changes 
in blood oxygen saturation which are then used to calculate the 
changes in tissue oxygen metabolism. This physiological param-
eter can be very useful in research and clinical studies to assess the 
functional state of tissue. In this work, we will overview the current 
IntroductIon
The wide-spread use of imaging methods that are sensitive to the 
cerebral oxygenation level of blood, such as blood oxygenation-level 
dependent functional magnetic resonance imaging (BOLD fMRI), 
has sparked significant interest in the properties and role of oxygen 
delivery and consumption in the brain, particularly during changes 
in brain function. In general, oxygen is transported to the brain by 
blood and it is delivered to tissue at the capillary level by diffusion. 
In tissue, oxygen diffuses until it is used up in cellular mitochon-
dria. With increases in neural activity, the cerebral metabolic rate of 
oxygen consumption (CMRO2) increases (Herscovitch et al., 1985; 
Fox et al., 1988; Fiat et al., 1993; Davis et al., 1998; Kim et al., 1999; 
Mayhew et al., 2000; Hyder et al., 2001; Shulman et al., 2001; Boas 
et al., 2003). In addition, the delivery (or supply) of oxygen to tis-
sue also increases through increases in cerebral blood flow (CBF) 
(Buxton and Frank, 1997; Davis et al., 1998; Hyder et al., 1998; Kim 
et al., 1999; Lauritzen, 2001; Zheng et al., 2002). The increase in CBF 
is produced at least in part by the dilation of feeding arteries, and 
hence, increases in cerebral blood volume (CBV) have also been 
observed (Berwick et al., 2005; Vanzetta et al., 2005; Hillman et al., 
2007; Kim et al., 2007). This general picture appears to be coherent 
because it is expected that increases in neural activity (e.g., synaptic 
transmission and firing rate) require additional energy, which is sup-
plied by increases in oxidative metabolism. As a result, blood flow 
increases to satisfy the consumption (or demand) of tissue oxygen. 
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Increases in neural activity evoke increases in the delivery and consumption of oxygen. 
Beyond observations of cerebral tissue and blood oxygen, the role and properties of cerebral 
oxygen delivery and consumption during changes in brain function are not well understood. 
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and introduces recent and preliminary findings to explore the mechanisms by which oxygen is 
delivered to tissue as well as the temporal dynamics of oxygen metabolism. Vascular oxygen 
tension measurements have shown that a relatively large amount of oxygen exits pial arterioles 
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decreases in tissue oxygen tension induced by increases in oxygen consumption are slow to 
evoked changes in CBF under control conditions. Preliminary findings obtained using flavoprotein 
autofluorescence imaging suggest cellular oxidative metabolism changes at a faster rate than 
the average changes in tissue oxygen. These issues are important in the determination of the 
dynamic  changes in tissue oxygen metabolism from hemoglobin-based imaging techniques 
such as blood oxygenation-level dependent functional magnetic resonance imaging (fMRI).
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knowledge of functional oxygen delivery and   consumption and 
introduce recent findings to explore the role of the large delivery 
of oxygen to tissue and the temporal dynamics of oxygen con-
sumption. Specifically, previously reported data from our group 
(Vazquez et al., 2010) will be used in combination with a model of 
the transport of oxygen to aid in the investigation of these questions. 
These data will also be used to explore the impact of vascular wall 
PO2 measurements on the longitudinal gradient of oxygen along 
the cerebro-vascular tree. Preliminary findings of the functional 
changes in tissue PO2 as a function of depth over superficial layers 
will also be explored. Lastly, preliminary findings of the dynamic 
changes in cellular oxidative metabolism with evoked function 
obtained using flavoprotein autofluorescence imaging (FAI) are 
also presented.
Background
The mammalian brain is very sensitive to the amount of oxygen. 
This is exemplified by the disruption of brain function within min-
utes after discontinuing oxygen supply (e.g., respiratory arrest). 
Oxygen in air is present at a concentration of 20.9% under standard 
temperature and pressure (i.e., 25°C and 1 atm). It is transported 
from air to the lungs by respiration and it dissolves in blood where 
it mostly binds hemoglobin in red blood cells. The ability of a 
medium such as blood (plasma) to dissolve oxygen is described 
by Henry’s Law and the solubility coefficient (α), which has been 
determined to be 1.39 × 10−3 mM/mmHg (Popel, 1989). In the 
lungs, the inspired oxygen tension is about 150 mmHg under stand-
ard body temperature and pressure (i.e., 37°C and fully saturated 
water vapor gas), setting an upper bound for the oxygen tension of 
blood. A single hemoglobin molecule is able to bind four oxygen 
molecules such that the total concentration of oxygen in blood 
depends mostly on the concentration of hemoglobin, although free 
oxygen dissolved in blood plasma, reported as the partial pressure 
or tension of oxygen in blood, also contributes a small amount. 
The affinity of oxygen to hemoglobin depends on the blood oxygen 
tension and it is described by the oxygen dissociation curve (ODC) 
(Popel, 1989; Jensen, 2004). It is worth noting that the ODC is 
influenced by temperature, pH and carbon dioxide tension (the 
latter two compose the Bohr effect). A common expression for 
the ODC is the Hill equation (Eq. 1) which is parametrized by 
the P50 (the oxygen tension at which blood hemoglobin is 50% 
saturated by oxygen) and the Hill coefficient (h). The kinetics of 
the association and dissociation of oxygen from hemoglobin have 
been determined to take tens of milliseconds under normal condi-
tions (Gibson et al., 1955; Popel, 1989). Hence, if an instantaneous 
equilibrium is assumed, the total concentration of blood concentra-
tion can be described by Eq. 1 as the sum of the oxygen dissolved 
in plasma (Cp) and the oxygen bound to hemoglobin, where [Hb] 
is the concentration of hemoglobin in blood. Using the values in 
Table 1, an arterial oxygen tension of 100 mmHg would correspond 
to a dissolved oxygen concentration (Cp) of 0.14 mM and a total 
oxygen concentration (Cc) of 6.56 mM.
CC
P
C
cp
p
h =+
+






4
1
50
[] Hb
α
 
(1)
A relatively simple model can be used to describe the transport 
of oxygen by conservation of mass assuming that a single vascular 
compartment with a linear axial and radial oxygen gradient is a 
reasonable approximation (Eq. 2 and Figure 1) (Valabregue et al., 
2003). In this fashion, the average amount of oxygen (represented 
by the product of the compartment’s volume Vc and the average 
oxygen concentration Cc) is described by the average amount of 
oxygen entering the compartment upstream (CBF Ca), the amount 
of oxygen leaving the compartment down-stream (CBF Cv) and 
the amount of oxygen delivered to tissue (represented by the right-
most term in Eq. 2). In the latter term, the transport of oxygen 
out of the vascular space (orthogonal to the direction of flow) is 
related to the product of the oxygen permeability and surface area 
of exchange (PSc) (see Table 1). Similarly, the average amount of 
oxygen in a tissue compartment (represented by the product of 
the tissue compartment volume Vt and the average tissue oxygen 
concentration Ct) can be simply described by the difference between 
the amount entering the tissue compartment and the amount of 
oxygen consumed (CMRO2) (Eq. 3). A more in-depth description 
of this model (Eqs 1–3) and its assumptions can be found in (Popel, 
1989; Valabregue et al., 2003).
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Cerebral oxygen tension is classically measured using polaro-
graphic oxygen microelectrodes (Fatt, 1976; Siesjö, 1978). A 
significant  advantage  of  this  method  is  that  it  can  quantify 
the absolute tension of free dissolved oxygen with good spa-
tial resolution (typical volumes of about 10 μm in radius or 
greater). A significant disadvantage of this method is its single 
point measurement and invasiveness since the electrode must be 
physically placed at the desired sampling location. In addition, 
the measurement of intra-vascular PO2 is generally limited to 
the surface of blood vessels which may not necessarily indicate 
the intra-vascular PO2, especially for larger arteries where the 
vascular wall is thick (a promising new method might overcome 
some of these shortcomings (Yaseen, et al., 2009)). Although 
other methods can be used to measure oxygen tension (e.g., 
phosphorescence quenching), most reports overviewed below 
used oxygen microelectrodes to measure oxygen tension in blood 
vessels and tissue.
Table 1 | Parameter values used for the model described in Eqs 1–3.
Parameter  Value  Remarks
[Hb]  1.72 mM  Vazquez et al. (2010)
α  1.39 × 10−3 mM/ mmHg  Popel (1989)
P50  38 mmHg  Gray et al. (1964)
h  2.73  Valabregue et al. (2003)
CBF0  150 ml/min  Kim et al. (2007)
PSc  612 ml/min  Medium-to-small arterial   
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oxygen delIvery
Oxygen is transported to the brain by the arterial vasculature and 
most of the blood oxygen is exchanged into tissue in cerebral capil-
laries by diffusion. Therefore, a longitudinal or axial oxygen con-
centration gradient exists between cerebral arteries and veins. In 
addition, the venous (or down-stream) concentration of oxygen 
directly depends on the flow rate. A few reports of the arterial and 
venous cerebral oxygen tension in the literature show that the largest 
drop in vascular PO2 occurs in tissue across capillaries (17 mmHg) 
(Vovenko, 1999) and between pre-penetrating pial arterioles and 
post-emerging pial venules (44 mmHg; Figure 2, Small Artery to 
Small Vein locations, or SmArt to SmVen, respectively).
Interestingly, the gradient of oxygen is decreasing along the 
traversal of blood within the arterial tree becoming significantly 
lower  in  small  pre-penetrating  pial  arterioles  (Vovenko,  1999; 
Vazquez et al., 2010). Specifically, in a report by Vovenko (1999) 
the resting arterial oxygen tension dropped by 23 mmHg prior to 
entering the capillaries. In a recent study by our group (Vazquez 
et al., 2010), the arterial oxygen tension dropped by 11 mmHg in 
the pial surface prior to the arteries penetrating into the cortex 
(Figure 2, medium to small artery locations). Similar measure-
ments in other tissues (e.g., muscle) have also shown a similar 
efflux of oxygen from arterial vessels (Duling and Berne, 1970). 
In many studies, vascular PO2 measurements are made at the ves-
sel wall, which underestimates the intra-luminal vascular PO2. A 
conventional correction to PO2 measurements at the vessel wall 
considers the wall thickness and the gradient of oxygen across the 
wall (Ivanov et al., 1999). In a study by Duling and Berne (1970) 
these two parameters were measured in cerebral arteries and they 
found an average PO2 gradient of about 1 mmHg/μm and an average 
wall thickness of 15% of the intra-luminal diameter. These find-
ings were used to perform a zero-order   correction of our arterial 
FIguRE 1 | Simplified diagram of the transport of oxygen from blood to 
tissue. The model in Eqs 2 and 3 consists of a vessel compartment and a 
tissue compartment, respectively, where the amount of oxygen per unit time is 
conserved in each compartment. The model implemented in this work 
assumed a linear intra-vascular oxygen gradient to be a reasonable 
approximation.
FIguRE 2 | Average resting cerebral PO2 gradient in tissue and pial 
vasculature (solid black line). PO2 measurements were obtained from the 
vessel wall and the intra-vascular PO2 (corrected) was estimated using oxygen 
gradient and wall thickness estimates from the literature (dashed black line). 
The average vessel diameter is also presented (solid red line) with its 
corresponding axis on the right. In the horizontal axis, “Lar” was used to 
denote the largest visible branch of the targeted pial artery (“ Art”) and vein 
(“Ven”). These locations are also referred to as large artery and large vein, 
respectively. “Sm” was used to denote the targeted pre-penetrating arterial 
branch (also called small artery) and post-emerging venous branch (small vein). 
“Med” was used to denote the branch location of measurement between the 
“Lar” and “Sm” locations in each artery and vein (also referred to as medium 
artery and medium vein). Error bars indicate the standard error (n = 6, 6, 9, 9, 
9, 6, and 6 for LarArt, MedArt, SmArt, Tissue, SmVen, MedVen, and LarVen, 
respectively). This data was adapted from Vazquez et al. (2010).
PO2 measurements obtained at the vessel wall and, as a result, the 
longitudinal PO2 gradient along the arterial tree slightly steepened 
to 16 mmHg (from 101.8 to 85.8 mmHg, Figure 2). In addition, Frontiers in Neuroenergetics  www.frontiersin.org  June 2010  | Volume 2  | Article 11  |  4
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of 3 Hz, amplitude of 1.5 mA, total   duration of 20 s, repeated every 
80 s. These parameters have been shown to produce consistent 
neural responses and robust hemodynamic responses (Masamoto 
et al., 2009). CBF was measured using a laser Doppler flowmeter 
(LDF) and it was observed to increase by 44 ± 12% (n = 9; stand-
ard error reported unless otherwise stated) over the last 10 s of 
the stimulation period, in part due to increases in the vascular 
diameter of arteries of about 5%. More importantly, PO2 was meas-
ured in pial arteries, pial veins and tissue locations using oxygen 
microelectrodes and, upon stimulation, vascular PO2 was observed 
to increase in pial arteries and veins at all the locations sampled 
(Figure 3). The average arterial oxygen tension was observed to 
increase by 4 ± 1 (n = 6), 5 ± 1 (n = 6) and 11 ± 2 mmHg (n = 9) 
at the large, medium and small pial artery locations, respectively, 
during the last 10 s of the stimulation period. Note that the arte-
rial longitudinal gradient decreased on average from 16 mmHg 
at rest to 10 mmHg during stimulation conditions. The average 
venous PO2  was observed to increase by 7 ± 2 (n = 9), 7 ± 2 (n = 6) 
and 5 ± 2 mmHg (n = 6) at the small, medium and large pial vein 
locations, respectively. Temporally, the earliest average increase in 
vascular PO2 was observed in medium and small pial arteries.
In summary, the longitudinal arterial PO2 gradient was observed 
to decrease with increase in function. This is due, at least in part, 
to the functional increase in CBF. In general, an increase in arterial 
oxygen tension will also increase the extra-vascular oxygen tension 
(Figure 1). To investigate the mechanism(s) behind the decrease in 
the longitudinal arterial PO2 gradient, our experimental data were 
used in combination with the model in Eqs 1 and 2 to estimate the 
required increases in extra-vascular PO2 to describe the data. For this 
exercise, the LDF data was assumed to represent CBF, the medium 
artery PO2 was used to represent the input PO2 of the vascular com-
partment (Ca) and the tissue PO2 was used as an estimate of the 
extra-vascular PO2 (Ct). The model was then used to compare the 
predicted output PO2 (Cv) with the measured small artery PO2  data 
(Figure 1). The values considered for the parameters of the model 
are listed in Table 1. Considering only the steady-state changes, 
it was calculated that a large increase in the extra-vascular PO2 is 
necessary to describe the small artery PO2 data (output) and lower 
resting extra-vascular PO2 levels. Recall that the tissue PO2 level was 
measured in these experiments at a depth of 300 μm which includes 
capillary exchange (Figure 4, top panel, and Table 1). The change 
in the extra-vascular PO2 was calculated to decrease as the resting 
extra-vascular PO2 level increased.
Another possibility is that the extra-vascular PO2 level does not 
change and that the increases in CBF (i.e., blood velocity) impact 
the permeability of oxygen. Under these assumptions, the relative 
change in PS was calculated to significantly drop with increases in 
CBF and this decrease grows as the resting extra-vascular PO2 level 
increases (Figure 4, bottom panel). Decreases in oxygen perme-
ability with increases in blood flow have been reported (Tsai et al., 
2003; Lamkin-Kennard et al., 2004; Chen et al., 2006), though not 
of this magnitude. To determine which mechanism(s)   contribute 
to significant hyper-oxygenation in arteries, it is necessary to assess 
the baseline PO2 at the pial surface as well as the magnitude of super-
ficial tissue PO2 changes with increased brain activity, if any. The 
PO2 of tissue is known to be heterogeneous, including that of the 
pial surface. This has been attributed to the relative heterogeneous 
the study by Vovenko, was performed under a microscope at high 
magnification using sharp microelectrodes that were carefully posi-
tioned inside the vessel wall in close proximity to the luminal space 
to avoid this potential source of error. In both studies a significant 
decrease in arterial PO2 was observed, hence showing that, similar 
to other tissues, cerebral arteries are indeed permeable to oxygen. 
The significance of this arterial oxygen gradient is that it allows for 
the control of the delivery of oxygen to down-stream vasculature 
through increases in blood flow.
It has been long hypothesized that this delivery of oxygen by the 
arterial vasculature serves to satisfy the metabolic demands of vascular 
cells and also the demands of surrounding tissue (Tsai et al., 2003). 
However, recall that the total efflux of oxygen depends on that bound 
to hemoglobin and the ODC. In arteries, PO2 is relatively high but the 
total amount of oxygen transported to tissue is not as large as that 
in capillaries. Nonetheless, measurements of the radial arterial PO2 
gradient beyond the vascular wall have shown that the oxygen tension 
in tissue surrounding arteries is significantly larger than the PO2 in 
capillaries (Duling et al., 1979; Sharan et al., 2008). This gradient was 
observed to take tens of micrometers to equilibrate with the average 
tissue oxygen tension. These findings indicate that sufficient oxygen 
escapes arterial blood and reaches surrounding tissue for consump-
tion and that capillaries are not the sole source of oxygen delivery. 
However, the functional role of this source of oxygen is unclear.
Lastly, after the passage of blood through arteries and capillaries, 
it enters the venous vasculature where it continually pools with blood 
from other cortical areas as the branching order decreases. In con-
trast to the arterial vasculature, no significant differences in oxygen 
tension were reported along the venous tree although significant 
variability in the oxygen tension within the draining venous tree 
was reported (Vovenko, 1999; Vazquez et al., 2010). Interestingly, 
both studies by Vovenko and our group reported a larger average 
PO2 in the largest sampled venous location compared to the smallest 
sampled venous location (by 3–5 mmHg) although these differences 
were not statistically significant. To account for potential errors stem-
ming from vascular wall measurements, the radial oxygen gradient in 
veins was measured to be 0.1 mmHg/μm (Vovenko, 1999; Tsai et al., 
2003). In addition, the venous vascular wall is thinner than that of 
arteries (about 10% of the venous lumen diameter) (Burton, 1954). 
These values were also used to perform a zero-order correction of 
the venous PO2 measurements and small increases in the venous PO2 
were obtained (Figure 2). Such increases in venous PO2 have also been 
reported in other tissues (Tsai et al., 2003). In the brain, this increase 
in venous PO2 has been attributed to the presence of arterio-venous 
shunts and the draining of blood from other parts of the brain with 
different metabolic demands (Tsai et al., 2003). 
arterIal PO2 changes durIng Increased neural actIvIty
It is well-known that increases in neural activity induce increases in 
CBF and that this dynamic process is responsible for the hyper-ox-
ygenation of both tissue and the down-stream venous vasculature. 
However, changes in arterial oxygenation with increases in neural 
activity had not been investigated. To this end, our group investi-
gated the impact of evoked neural activity on arterial, tissue and 
venous PO2 in the isoflurane-anesthetized rat (Vazquez et al., 2010). 
The neural stimulus consisted of electrical stimulation of the rat’s 
forelimb with the following parameters: 1 ms pulses at a frequency Frontiers in Neuroenergetics  www.frontiersin.org  June 2010  | Volume 2  | Article 11  |  5
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estimate of the tissue CMRO2 response, both the upstream arte-
rial PO2 and the intra-cortical area of exchange (by way of an 
increase in CBV) need to increase in order to fully describe the 
measured changes in tissue PO2 (Vazquez et al., 2008). The data and 
simulation work in that study found that the delivery of oxygen 
required a peak increase of 14 mmHg in tissue PO2 to describe 
the data. The increase in oxygen delivery can be allocated as con-
tributions from CBF increases alone (6 mmHg for a constant 
input oxygenation), increases in the input arterial oxygenation 
(4 mmHg for an increase of 10 mmHg in arterial PO2) and other 
mechanisms (4 mmHg), such as an increase in exchange area. The 
data in Figure 3 shows similar increases in arterial oxygenation 
and the residual increase in oxygen delivery can be attributed to 
increases in exchange area (CBV). In fact, functional increases 
in intra-cortical blood volume have been measured using MRI 
in similar experiments (Kim et al., 2007). Alternatively, another 
mechanism to increase the delivery of oxygen can be through a 
shift in the ODC due to pH increases and the binding of CO2 to 
hemoglobin (i.e., the Bohr effect). To examine this mechanism, 
our previous simulation work was expanded to consider the pos-
sibility of shifts in the blood P50 (Eq. 1) as the sole source of the 
increases in tissue oxygen delivery (i.e., no arterial PO2 or exchange 
distribution of capillaries, arteries and veins in the brain (Popel, 
1989; Tsai et al., 2003). Nonetheless, preliminary tissue PO2 meas-
urements at the pial surface and deeper in tissue performed in 
our laboratory have shown that the surface PO2 level is higher than 
that at 300 μm in depth, but the functional increase in tissue PO2 
is somewhat smaller at the surface compared to deeper in tissue 
(Figure 5). Other reports in the literature have also found a higher 
tissue PO2 near or at the pial surface (Masamoto et al., 2004; Sharan 
et al., 2008). Therefore, we conclude that the increase in arterial PO2 
requires a decrease in the arterial permeability of oxygen in addition 
to the increase in CBF which contribute to the hyper-oxygenation 
of surrounding tissue.
tIssue oxygen delIvery durIng Increased neural actIvIty
The increase in arterial oxygen tension supplies the sub-serving 
tissues with a relatively large amount of oxygen. Computer simu-
lation work performed by our group determined that, given an 
FIguRE 3 | (Top) Change in oxygen tension at sampled large, medium 
and small pial arteries (labeled LarArt, MedArt, and SmArt, respectively) 
due to evoked somato-sensory stimulation (gray bars) relative to their 
respective pre-stimulation level. The small pial artery measured consisted 
of a pre-penetrating arterial branch just prior to its intra-cortical penetrating 
location over the activate area. The medium and large locations sampled 
consisted of the parent branches of the sample small artery sampled. 
(Bottom) Change in oxygen tension at the vessel wall of sampled small, 
medium and large pial veins (labeled SmVen, MedVen, and LarVen, 
respectively) relative to their respective pre-stimulation level. Similar to the 
small artery location, the small pial vein location was selected just after its 
intra-cortical emerging location over the active area and the medium and large 
vein locations corresponded to parent branches. The corresponding baseline 
PO2 for each location sampled is reported in the legend. Error bars indicate the 
standard error (n = 6, 6, 9, 9, 9, 6, and 6 for LarArt, MedArt, SmArt, Tissue, 
SmVen, MedVen, and LarVen, respectively). This data was adapted from 
Vazquez et al. (2010).
FIguRE 4 | (Top) Model prediction of the increase in the extra-vascular 
PO2 (Ct) necessary to represent the increase in medium artery PO2 (input, 
Ca) and small artery PO2 (output, Cv) considering the measured increase in 
CBF and a constant PSc (Eq. 2, Figure 1). A higher extra-vascular PO2 level 
requires a smaller activation-evoked increase in extra-vascular PO2 to describe 
the data (i.e., small artery PO2). (Bottom) Model prediction of the decrease in 
PSc (i.e., oxygen permeability) necessary to describe the increase in medium 
and small artery PO2 during increased neural activity while maintaining the 
extra-vascular PO2 level constant.Frontiers in Neuroenergetics  www.frontiersin.org  June 2010  | Volume 2  | Article 11  |  6
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spiking activity. Thompson et al. (2003) measured the changes in 
tissue oxygen tension and spiking activity with visual stimulation 
in the primary visual cortex of cats. They showed that increases in 
spiking activity to preferred-oriented visual stimuli were accompa-
nied by decreases in tissue oxygen tension due to a dominant meta-
bolic response. On the other hand, this  CMRO2 -driven decrease 
was not evident during the presentation of non-preferred orien-
tation visual stimuli which did not elicit significant changes in 
spiking activity.
changes In tIssue PO2  Induced By changes In CMRO2
The dynamic changes of tissue oxygen tension can be measured using 
oxygen microelectrodes as done by Thompson and others (Ances 
et al., 2001; Thompson et al., 2003; Masamoto et al., 2003). However, 
this method does not directly measure the functional changes in 
CMRO2 because the tissue oxygen tension is also manipulated by 
the concomitant CBF response. Because CMRO2 and CBF modulate 
the oxygen tension of tissue in opposite fashion, the dynamics of 
oxidative metabolism have been difficult to measure even when 
using oxygen specific methods such as oxygen microelectrodes. One 
solution to overcome this difficulty is to suppress the evoked CBF 
area increases). The results from this simulation show that an 
average increase in P50 from 38 to 43.7 mmHg was necessary 
to fully describe the measured changes in tissue PO2 (Figure 6). 
Under resting conditions, arterio-venous differences in blood pH 
and PCO2 are about −0.05 and 6 mmHg, respectively (Vovenko, 
1999), which would in turn increase the P50 of blood by about 
1.5 mmHg (Severinghaus, 1979). Measurements of the changes in 
cerebral pH and/or PCO2 with function are necessary to determine 
if this mechanism contributes to the delivery of oxygen to tis-
sue. Interestingly, this mechanism has also been proposed as that 
responsible for the slight increases in the venous PO2 longitudinal 
gradient (Tsai et al., 2003).
oxygen consumptIon
Oxygen in tissue is consumed in mitochondria as part of oxidative 
metabolism. Although this metabolic pathway yields much more 
energy than glycolysis, the role of oxidative metabolism in satisfy-
ing the energetic needs of neural tissue during increased function 
has been extensively debated (Shulman et al., 2001). This is partly 
due to the lack of adequate methods to directly measure oxida-
tive metabolism. For example, methods such as O15-PET and O17-
NMR are directly sensitive to CMRO2 but require a steady-state of 
exogenous label to reach tissue (Herscovitch et al., 1985; Fiat et al., 
1993). Nonetheless, these and similar techniques have been used to 
show measurable increases in oxidative metabolism with increases 
in neural activity (Hyder et al., 2001; Rothman et al., 2003). Much 
of the scientific interest to measure functional changes in cerebral 
metabolism stem not only from its physiologically relevant role 
in maintaining function, but also in part due to its sensitivity to 
FIguRE 5 | Preliminary measurements of the increase in tissue PO2  that 
result from increases in somato-sensory stimulation at two different 
depth locations: at the cortical surface (0 μm, blue line) and 300 μm 
below the surface (green line). In this experiment, the stimulation period 
was significantly shorter (3 s), hence the changes in PO2 were not as large as 
those in Figure 3. Although these functional responses were not obtained 
simultaneously, CBF changes were recorded at both depths using LDF and 
the evoked CBF responses were essentially the same. The Ps O2 at the surface 
was about 10 mmHg larger than that at 300 μm depth.
FIguRE 6 | Effect of the blood P50 (Eq 1) on the delivery of oxygen to 
tissue. A 15% increase in P50 (top panel) was found to represent the tissue PO2 
data (middle panel; Vazquez et al., 2008). (Bottom panel) The estimated 
changes in P50 were temporally similar to the changes in CBF measured in that 
study although lagged the CBF response (measured using LDF) by about 1.5 s 
at 50% amplitude. Increases of this magnitude are not likely to be 
physiological; however, this mechanism may contribute to the hyper-
oxygenation of tissue during increases in neural activity.Frontiers in Neuroenergetics  www.frontiersin.org  June 2010  | Volume 2  | Article 11  |  7
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(blue lines in Figures 7A,B). In fact, the CMRO2-driven decreases in 
tissue PO2 under suppressed-CBF conditions (blue line in Figure 7C) 
appear to be slower than the evoked CBF response measured by LDF 
under control conditions (green line in Figure 7C). In addition, the 
magnitude of the decreases in tissue PO2 due to evoked increases in 
CMRO2 was found to be very well correlated with the field poten-
tial responses of individual stimuli (Masamoto et al., 2008). These 
data were supplied to the model described by Eqs 1–3 to estimate 
the dynamic changes in CMRO2. The results obtained showed that 
the calculated CMRO2 dynamics lagged changes in CBF by 2.2 s 
(measured as the time-to-50% peak during the response onset) 
(Vazquez et al., 2008). Collectively, these results suggest that tem-
poral dynamics of the average CMRO2 response are as slow as those 
of the hemodynamic response, if not slower.
dynamIcs of cellular CMRO2 changes measured usIng faI
In general, two methods are known to be sensitive to the cellular 
oxidative metabolic rate, both of which are light-based and inva-
sive. One relies on the absorption of light by cytochrome-c, a mito-
chondrial protein responsible for transporting electrons between 
complexes III and IV in the electron transport chain of the TCA 
cycle (Chance, 1968). The other relies on the fluorescence of tissue 
proteins that also participate in cellular metabolism. Much of the 
intrinsic fluorescence of living tissues, or autofluorescence, stems 
from the reduced form of the coenzyme nicotinamide adenine dinu-
cleotide (NADH) and the oxidized form of flavin adenine dinucle-
otide (FAD) (Chance, 1968; Huang et al., 2002). These proteins are 
directly involved in the TCA cycle as proton carriers for the electron 
transport chain where NADH and FADH2 are oxidized to NAD and 
FAD, respectively. While NADH is fluorescent, NAD+ is not, and the 
metabolic rate could be assessed by decreases in the fluorescence 
of NADH (Huang et al., 2002; Reinert et al., 2004). Different from 
NADH, its analog FADH2 is not fluorescent, but its oxidized form 
(FAD, also called flavoprotein) is fluorescent; hence, increases in 
response. For this purpose, our group implemented an experimental 
condition which relies on the administration of a clinical vasodilator, 
sodium nitroprusside (sNP) (Fukuda et al., 2006; Nagaoka et al., 
2006; Masamoto et al., 2008). This agent dilates the vasculature effec-
tively suppressing evoked increases in CBF (and CBV) due to neural 
stimulation. However, the delivery of this agent significantly reduces 
the systemic blood pressure (its intended clinical use). To verify that 
this agent does not disrupt neural function, measurements of local 
field potential and   spiking activity with evoked stimulation prior to, 
during and after the administration of the agent were performed. 
These experiments showed that the evoked spiking and local field 
potential activity during the agent administration was not signifi-
cantly different than the activity prior to or after agent administra-
tion (Fukuda et al., 2006; Masamoto et al., 2008).
Our group has used this suppressed-CBF condition to investi-
gate the CMRO2 response properties to evoked neural activity. In 
these experiments, BOLD fMRI and optical imaging of intrinsic 
signal (OIS) were used to represent the oxygenation of blood, and 
oxygen microelectrodes to represent the oxygenation of tissue, in 
anesthetized rats and cats (Fukuda et al., 2006; Nagaoka et al., 2006; 
Moon et al., 2007; Masamoto et al., 2008). OIS was implemented 
using 620 nm transmitted light which is sensitive to the absorp-
tion of light by deoxygenated hemoglobin and therefore has simi-
lar sensitivity to BOLD fMRI. In one of these reports (Masamoto 
et al., 2008), both tissue PO2 and OIS were measured during evoked 
somato-sensory stimulation for 10 s under control and suppressed-
CBF conditions in the isoflurane-anesthetized rat. Somato-sensory 
stimulation under control conditions evoked an increase in CBF of 
48 ± 10% (n = 5; measured using LDF), while under suppressed-CBF 
conditions, the magnitude of the CBF response was significantly 
diminished, showing increases of 3–4% over baseline. More impor-
tantly, under suppressed-CBF conditions, the dynamic decreases in 
tissue PO2 and in blood oxygenation (measured by OIS) induced by 
increases in CMRO2 were considerably slow, taking over 10 s to peak 
FIguRE 7 | Averaged tissue PO2 (A) and blood oxygenation ((B), OIS) 
changes to forelimb somato-sensory stimulation (1 ms, 1.2 mA electrical 
pulses delivered at 6 Hz for 10 s indicated by gray bars) under control 
(red lines) and suppressed-CBF conditions (blue lines). (C) Normalized time 
series (baseline to peak) show that the CBF response under control 
conditions measured by LDF is faster than CMRO2-induced blood 
oxygenation (OIS) changes. This data was adapted from Masamoto  
et al. (2008).Frontiers in Neuroenergetics  www.frontiersin.org  June 2010  | Volume 2  | Article 11  |  8
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OIS (using 610 nm wavelength light) was estimated to be about 
450 μm, suggesting that metabolic imaging is more specific to the 
neuronal activation sites than hemodynamic imaging. Collectively, 
these studies have demonstrated the sensitivity and feasibility of 
this method to map functional metabolic responses in vivo. This 
method was recently implemented in our laboratory to investigate 
the temporal dynamics of the CMRO2 response.
Preliminary  FAI  experiments  have  been  performed  in  our 
laboratory  during  somato-sensory  stimulation  in  isoflurane-
anesthetized rats. The goal of these experiments is to determine 
the temporal evolution of the functional CMRO2 response with 
increases in neural activity. Hence, these experiments have been 
carried out under suppressed-CBF conditions to avoid potential 
artifacts stemming from the stimulation-evoked vascular (CBF 
and CBV) response. Images were acquired using an epi-fluores-
cence microscope with filtered excitation light of 470 ± 20 nm and 
emission band at 525 ± 25 nm at 10 frames per second. Somato-
sensory stimulation at a frequency of 12 Hz for 4 s shows that 
the FAI signal increase (brightening) is localized to the forelimb 
  somato-sensory area and that it is sustained during the stimula-
tion period (Figure 8). More importantly, FAI vascular response 
artifacts have been mitigated under suppressed-CBF conditions as 
evidenced by the gray-background intensity of the blood vessels. 
Therefore, we believe that the data presented, are mostly sensitive 
to the changes in the cellular oxidative metabolic rate. To further 
investigate the temporal differences between tissue and blood oxy-
genation signals driven by changes in CMRO2, FAI and OIS signals 
were measured in separate experiments using a longer stimulation 
period (15 s of forelimb stimulation at a frequency of 3 Hz). The 
FAI signal showed very fast temporal changes reaching 90% of peak 
amplitude within 1.5 s of stimulation onset and a rise time constant 
of 0.5 s for the onset portion of the response (Figure 9, left panel). A 
sustained plateau period was observed in the FAI response followed 
by a decrease during and after the stimulation period. By contrast, 
the changes in blood oxygenation measured by OIS showed slower 
temporal changes, reaching 90% of the peak decrease in 5 s with a 
rise time constant of 1.9 s (Figure 9, right panel). This method and 
the properties of the measured FAI responses are currently under 
the metabolic rate can be assessed by increases in the fluorescence 
of FAD (Hassinen and Chance, 1968; Huang et al., 2002; Reinert 
et al., 2004). More importantly, FAD fluorescence changes in vivo are 
generally larger and easier to detect than that of NADH, although 
its concentration in tissue is lower (Reinert et al., 2004).
Flavoprotein autofluorescence measurements were pioneered by 
Dr. Britton Chance and has been extensively used to investigate mus-
cle function and ex vivo cellular function in various tissues (Chance 
et al., 1962, 1979; Garland et al., 1967; Chance, 1968; Shuttleworth 
et al., 2003; Kasischke et al., 2004; Skala et al., 2007). Recently, FAI 
was adapted by several groups to image brain functional metabolism 
in vivo. Shibuki et al. (2003) implemented and verified the signal 
source of this method in rat brain slices and in vivo. They stimulated 
the rat cortex directly with a metal electrode and observed large 
sub-linear increases in FAD fluorescence as a function of stimulus 
frequency (as large as 20% for 100 Hz stimuli). They also used a 
more natural mechanical stimulus of the hind limb (50 Hz vibra-
tion) that lasted 1 s and produced increases in FAD fluorescence of 
about 3% in the somato-sensory cortex. The increase in fluorescence 
peaked 1 s after stimulation onset and was followed by an equally 
large decrease in signal that took longer to subside. They hypoth-
esized that the signal decrease was due to the stimulus-evoked CBF 
(and CBV) response that absorbed the FAD fluorescence emission. 
To investigate this possibility, they applied a nitric oxide inhibitor 
(NG-nitro-l-arginine) topically onto the cortex to reduce the CBF 
response and this condition indeed reduced the magnitude of the 
negative portion of the autofluorescence response. In another study, 
Reinert et al. (2004) studied FAI in the cerebellar cortex of mice 
using direct electrical stimulation and also found large increases in 
FAD fluorescence that were followed by a significant and prolonged 
decrease in fluorescence. They attributed this bi-phasic response 
to a time-dependent change in the metabolic cascade (a fast initial 
oxidation of FAD followed by a larger overall reduction in FAD) and 
to different metabolic contributions from neurons and glial cells. 
Lastly, Husson et al. (2007) demonstrated the use of FAI to map the 
orientation domains in the cat visual cortex. In this study, the spatial 
specificity of the orientation map obtained by FAI was estimated 
to be about 300 μm while the specificity of the map obtained by 
FIguRE 8 | Average FAI and OIS image sequence during somato-sensory 
stimulation of the rat forelimb (electrical pulses delivered at a frequency 
of 12 Hz for 4 s) under suppressed-CBF conditions. Each frame shown 
consists of the average of 10 consecutive images (effective resolution of 1 s;  
the time of the last image averaged indicated under each image) that  
have been subtracted from an average pre-stimulation image. Frames  
with a red-dot on the top-right corner indicate frames acquired during 
stimulation.Frontiers in Neuroenergetics  www.frontiersin.org  June 2010  | Volume 2  | Article 11  |  9
Vazquez et al.  Brain oxygen delivery and consumption
increases in CMRO2 have been consistently observed. Moreover, 
the temporal evolution of the tissue PO2 changes are consistently 
slower than the neurally-evoked changes in CBF elicited by the 
same stimulus under normal conditions. Preliminary experiments 
performed using FAI indicate that cellular oxidative metabolism 
changes at a faster rate than the average changes in tissue and blood 
oxygenation. This may be due to the small volume occupied by 
mitochondria, but formal experiments are necessary to determine 
the relationship between cellular oxidative metabolism and blood 
oxygenation. Nonetheless, this method shows great promise at elu-
cidating the functional properties and dynamics of CMRO2.
The findings described in this work have considerable implica-
tions for the quantification of the changes in CMRO2 (and blood 
oxygen  saturation)  from  hemoglobin-based  imaging  techniques 
like  BOLD  fMRI  and  deoxygenated  hemoglobin-weighted  OIS. 
The models used to calculate CMRO2 from blood oxygenation data 
typically assume that arterial blood is fully saturated with oxygen 
and that the delivery and consumption of oxygen is rapid such that 
changes in venous blood oxygen saturation reflect the changes in 
tissue oxygen consumption. In this review, experimental support is 
presented for arterial oxygen saturation levels that are high but not 
100%, particularly at the level of intra-cortical arteries. It is our opin-
ion that for typical fMRI studies, where voxel sizes span millimeters, 
an arterial oxygen saturation level near 100% is probably a reasonable 
assumption. However, for intra-cortical voxels in higher resolution 
studies (e.g., voxel sizes of hundreds of micrometers), the arterial 
oxygen saturation level has dropped significantly and the assumption 
of fully saturated arterial blood may introduce significant errors to 
the CMRO2 calculation. This can be potentially corrected if the input 
oxygen saturation is known. Notwithstanding, lower-resolution cali-
brated fMRI studies or ROI-wide analyses of calibrated fMRI data are 
not likely to be significantly impacted by this source of error. Another 
potential issue is that of blood volume changes. Traditionally, arte-
rial blood was thought to be fully saturated with oxygen and does 
not contribute a BOLD signal change regardless of arterial blood 
volume changes, such that only changes in venous blood volume 
and saturation contribute to the BOLD signal (Buxton et al., 2004; 
Davis et al., 1998; Kim et al., 1999). There is a growing consensus 
that the changes in arterial volume are significantly larger than those 
of venous volume (which, like capillary blood volume, appear to be 
investigation in our laboratory. To summarize, the temporal evo-
lution of the activation-evoked changes in FAI under suppressed-
CBF conditions is significantly faster than that of OIS or tissue PO2 
signals (Figure 7), indicating that the changes in cellular oxidative 
metabolism are indeed rapid and take significantly longer to be 
reflected in the average oxygen tension of tissue and blood.
concludIng remarks
Increases in neural activity evoke increases in both CBF and CMRO2. 
These increases have been thought to reflect the metabolic demands 
of tissue. However, in terms of oxidative metabolism, the delivery 
of oxygen largely exceeds the consumption of oxygen in tissue. 
The delivery of oxygen is driven by the increases in CBF and its 
  associated increases in CBV, but additional mechanisms are neces-
sary to describe observations of tissue oxygen delivery. Arterial blood 
is highly saturated with oxygen and measurements of the vascular 
oxygen tension have shown that a relatively large amount of oxygen 
diffuses out of arteries prior to capillaries. This oxygen gradient along 
the arterial vasculature allows the mechanisms regulating CBF to 
also regulate the delivery of oxygen to sub-serving areas. In addition, 
neurally-evoked increases in CBF are also accompanied by increases 
in the arteriolar oxygen tension. This increase in arterial oxygenation 
contributes not only to the down-stream delivery of oxygen to tissue, 
but also to delivery of additional oxygen to extra-vascular spaces sur-
rounding the arterioles. The supply of arterial oxygen to tissue has 
been hypothesized as necessary to homogenize the distribution of 
tissue oxygen. Nonetheless, other mechanisms beyond the increase 
in CBF and upstream oxygenation are necessary to fully describe 
the delivery of oxygen to tissue during evoked neural activity. While 
measurements of the tissue oxygen tension with increases in neural 
activity indicate that the role of CBF is not to maintain a constant 
average tissue oxygen tension, it is possible that the transient increases 
in tissue oxygen are necessary to maintain a minimum intra-cellular 
oxygen tension. Further study is necessary to determine the role of 
oxygen delivery to tissue with changes in neural activity, particularly 
in combination with the temporal dynamics of CMRO2.
The dynamics of tissue oxygen consumption have been difficult 
to measure because CMRO2 and CBF modulate the oxygenation of 
tissue in opposite fashion. By suppressing the neurally-evoked CBF 
response, functional decreases in tissue oxygen tension elicited by 
FIguRE 9 | Changes in oxidative metabolism induced by somato-sensory 
stimulation (3 Hz for 15 s) as detected in tissue and blood oxygenation 
using FAI (left panel) and OIS (right panel), respectively. These time series 
were averaged over a ROI covering the forelimb area in one animal. The FAI 
signal reached 90% peak in less than 2 s, while OIS signal took about 5 s to 
reach 90% peak.Frontiers in Neuroenergetics  www.frontiersin.org  June 2010  | Volume 2  | Article 11  |  10
Vazquez et al.  Brain oxygen delivery and consumption
Tissue Po2 DepTh experimenTs
An optical imaging experiment (620 ± 5 nm transmitted light) was 
initially performed to map the somato-sensory area for PO2 micro-
electrode placement (Vazquez et al., 2010). Tissue PO2 measure-
ments were performed using an oxygen microelectrode (APOX, 
Unisense, Aarhaus, Denmark) with tip diameter of 30 μm. The 
oxygen microelectrode was penetrated as close as possible to the 
activation focus location to a depth of 300 μm perpendicular 
to the cortical surface using a micromanipulator. A LDF probe 
(Perimed, Stockholm, Sweden) was placed over the cortical sur-
face covering the tissue PO2 probe location. The changes in tissue 
PO2 and LDF were recorded during somato-sensory stimulation 
(1 ms pulses at 1.5 mA for 3 s at a frequency of 6 Hz repeated 
every 35 s, 10 times) at this depth (300 μm) and also at the cortical 
surface (0 μm). The oxygen microelectrode was calibrated before 
and after each experiment with 0%, 21%, and 100% oxygen in 
saline solution at 37°C. In addition, the stability of the current 
reading was checked before and after each experiment to ensure 
reliable measurements. 
FAi AnD Ois experimenTs
Flavoprotein  autofluorescence  images  were  acquired  over  a 
5.5 × 4.1 mm2 area using an epi-fluorescence macroscope (MVX-10, 
Olympus,  Tokyo,  Japan)  and  a  digital  cooled-CCD  camera 
(CoolSnap HQ2, Photometrics, Princeton, NJ, USA)   during soma-
to-sensory stimulation of the rat forelimb. A mercury lamp light 
source coupled to a low-noise power supply (Opti-quip, Inc.) was 
used. The transmitted light was filtered between 450 and 490 nm 
while the camera recorded the fluorescence emission between 500 
and 550 nm at 10 frames per second. Images were acquired under 
suppressed-CBF conditions, which required the intra-venous infu-
sion of sNP (2 mg/kg in saline) (Masamoto et al., 2008). The infu-
sion rate of the sNP was adjusted to maintain a mean arterial blood 
pressure between 40 and 45 mmHg over the course of the stimula-
tion experiment. Two different forelimb stimulation experiments 
were performed: (1) 1 ms, 1.5 mA pulses at a frequency of 12 Hz for 
4 s every 16 s repeated 10 times; (2) 1 ms, 1.5 mA pulses every 3 Hz 
for 15 s every 45 s repeated eight times. The infusion of the agent 
was terminated after approximately 30 min. FAI experiments were 
followed by optical imaging OIS experiments. Oblique light guides 
transmitting filtered red light (620 nm) were used for illumination 
and a matching barrier filter was placed prior to the camera. Prior 
to averaging, a ROI was outlined over the skull or dental acrylic to 
regress out unwanted fluctuations stemming from fluctuations in 
the light source from all the acquired images. The data from all the 
trials in an experiment were then averaged and a ROI time series 
were generated. The activation area ROI was obtained by threshold-
ing a difference image obtained by averaging the images 2 s prior 
to stimulation onset and the two images obtained 2 s immediately 
after   stimulation onset.
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small) (Lee et al., 2001; Kim et al., 2007; Vazquez et al., 2010). As a 
result, changes in arterial volume (and saturation) likely contribute a 
BOLD signal change. The impact and/or necessity of arterial BOLD 
signal contributions to traditional calibrated fMRI models needs to 
be investigated. Lastly, the temporal scale of the changes in cellular 
oxidative metabolism (as indicated by FAI) and blood oxygenation 
(as indicated by OIS and PO2) is significantly different, even though 
the temporal changes between tissue PO2 and blood oxygenation are 
closer. These findings suggest that calculated CMRO2 values using 
traditional calibrated fMRI models over transition regions are largely 
underestimated with respect to cellular oxidative metabolism, but to 
a lesser extent with respect to the average oxygenation of tissue. At 
least several models have been published that incorporate an arterial 
compartment and non-steady CMRO2 dynamics (Zheng et al., 2005; 
Huppert et al., 2007; Uludag et al., 2009). The error introduced by 
these assumptions needs to be evaluated to determine appropriate 
models that can accurately quantify the changes in tissue CMRO2.
mATeriAls AnD meThODs
The experimental methods for the vascular PO2 measurements are 
reported in Vazquez et al. (2010), and those of the tissue PO2 measure-
ments recorded under control and suppressed-CBF conditions are 
reported in Masamoto et al. (2008) and Vazquez et al. (2008). Only 
new, previously unreported studies are described in this section. 
Five male Sprague-Dawley rats were used in this work (n = 2 for 
the tissue PO2 depth experiments and n = 3 for the FAI experiments) 
following an experimental protocol approved by the University 
of Pittsburgh Institutional Animal Care and Use Committee. The 
experimental procedure used was similar to our previous studies 
(Masamoto et al., 2008; Vazquez et al., 2010). Briefly, the animals 
were initially anesthetized using isoflurane (5% for induction, 2% 
for surgery), nitrous oxide (50–65%) and oxygen (35–50%) for 
intubation and placement of catheters in the femoral artery and 
femoral vein. The respiration rate and volume were controlled using 
a ventilator. After intubation, the animals were placed in a stere-
otaxic frame and the skull was exposed over the somato-sensory 
area. A well was made using dental acrylic surrounding an area 
5 mm × 7 mm on the left side of the skull, centered 3.5 mm lateral 
and 1.5 mm rostral from Bregma. The skull in this area was then 
removed using a dental drill. The dura matter was resected and the 
CSF fluid was released around the fourth ventricle area to minimize 
herniation. The well and the CSF release areas were then filled 
with 1.0% agarose gel at body temperature1. Two needle electrodes 
were placed in the right forepaw between digits 2 and 4 for electri-
cal stimulation. The anesthesia and breathing mixture were then 
changed to isoflurane (1.2–1.4%), oxygen (∼10%) and air (∼90%) 
for experimental recording. Rectal temperature was maintained at 
37°C throughout with a DC temperature control module. The arte-
rial blood pressure, respiration rate, heart rate, rectal temperature, 
end-tidal CO2 tension and isoflurane level were monitored and 
recorded using a polygraph data acquisition software.
1This preparation opens the possibility of oxygen in room air being supplied throu-
gh the craniotomy. In our experiments, we observed while placing the PO2 probes 
that the PO2 gradient would settle close to the pial surface PO2 level a few hundred 
micrometers over the cortical surface.  In addition, in placing the PO2 probes over 
the superior surface of arteries, the PO2 reading would increase prior to the probe 
reaching an artery.  These observations indicated that a significant amount of oxy-
gen is not likely supplied through the craniotomy.Frontiers in Neuroenergetics  www.frontiersin.org  June 2010  | Volume 2  | Article 11  |  11
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